Stay updated on Elranatamab Combo in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.
Latest updates to the Elranatamab Combo in Myeloma Clinical Trial page
- Check2 days agoChange DetectedThe page now includes related topics: Multiple myeloma and MedlinePlus Genetics. This is a minor addition to related topics and does not affect core study information; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check9 days agoChange DetectedAdded 85 recruitment locations across multiple countries, expanding where patients can enroll.SummaryDifference4%
- Check16 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics to the page.SummaryDifference0.1%
- Check23 days agoChange DetectedDeleted references to "Multiple myeloma" and related topics ("MedlinePlus Genetics") from the Study Details page.SummaryDifference0.1%
- Check38 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2, indicating a minor metadata update that does not alter core study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check45 days agoChange DetectedAdded three new study sites: Kantonsspital Winterthur (Winterthur, Switzerland), The First Affiliated Hospital of Soochow University (Suzhou, Jiangsu, China), and Southern Medical University Nanfang Hospital (Guangzhou, Guangdong, China). The total number of locations is now 76 and the recruitment status is Active, not recruiting.SummaryDifference0.8%
Stay in the know with updates to Elranatamab Combo in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.